News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Alper Topal: The Keynote 921 study failed for CRPC
Alper Topal/researchgate.net
Mar 18, 2025, 12:35

Alper Topal: The Keynote 921 study failed for CRPC

Alper Topal, Medical Onoclogist at Gülhane Training and Research Hospital, shared a paper Daniel P. Petrylak and colleagues authored on X:

“The Keynote 921 study failed for CRPC.

mPFS was 8.6 months in the pembro arm compared to 8.3 months in the placebo arm.mOS was 19.6 months in the pembro arm compared to 19 months in the placebo arm. Grade 3≥side effects were more common in the pembro arm.”

Pembrolizumab Plus Docetaxel Versus Docetaxel for Previously Treated Metastatic Castration-Resistant Prostate Cancer: The Randomized, Double-Blind, Phase III KEYNOTE-921 Trial

Authors: Daniel P. Petrylak et al.

Alper Topal

Alper Topal Andrew J. Armstrong Andries M. Bergman cancer Charles Schloss Christian H. Poehlein Daniel P. Petrylak Eric Levesque Ernesto Korbenfeld Gero Kramer Howard Gurney Karim Fizazi Loic Mourey Margitta Retz Maria De Santis Meital Levartovsky Nobuaki Matsubara OncoDaily Oncology Pawel Zalewski Raffaele Ratta Ray Manneh Ray McDermott Russell Pachynski Rustem Gafanov Seok Soo Byun Sergio Bracarda Tilman Todenhofer Winald Gerritsen Xin Tong Li
Special Coverage
Blog
May 29, 2025, 22:49
European Liver Patients'​ Association: The Role of Research and Innovation in Advancing Liver Cancer Therapies
Opinion
May 29, 2025, 22:38
Prerana Jha on ctDNA Molecular Profiling in Indian Lung Cancer Patients Study
Blog
May 29, 2025, 22:33
Ash Tewari Discusses Prostate Cancer Risk and Screening Guidelines - Mount Sinai Department of Medicine
Insight
May 29, 2025, 22:26
Alberto Puccini Shared Insights from AACR 2025 Update at Bari Congress
Blog
May 29, 2025, 22:19
Wafaa M Rashed Highlights PAPERI Blog on Prenatal Genetic Testing Policy in Africa by Mutaz Mohammed
Opinion
May 29, 2025, 22:12
ELPA Highlight Liver Cancer Awareness and Prevention During European Week Against Cancer
Opinion
May 29, 2025, 22:07
Lacy Hubbard: HPV Prevention is About Education, Screening and Treatment are About Access
Blog
May 29, 2025, 22:03
Mohamed Elazab Announced “From Early On, You’re Safe” – A Comprehensive Cancer Prevention Campaign in Kafr El-Sheikh
Insight
May 29, 2025, 21:57
European School of Oncology: Apply for Basics in Breast Cancer Surgery course by June 29
Opinion
May 29, 2025, 21:49
Association of European Cancer Leagues Shared a New Position Paper on PFAS free future
Opinion
May 29, 2025, 21:41
To Record or Not to Record – Olumide Ofinran on Patient Requests During Cancer Diagnosis Consultations
Blog
May 29, 2025, 21:35
Toufic Kachaamy: Are the rich, famous and powerful treated differently when it comes to cancer screening?